Lionco Pharmaceutical Group Inc. (603669)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
6. 18
+0.04
+0.6515%
¥
3.57B Market Cap
- P/E Ratio
0.4% Div Yield
21.59M Volume
- Eps
¥ 6.14
Previous Close Want to track 603669 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.04 |
| | | - | 0.07 |
| | | - | 0.04 |
| | | - | 0.04 |
| | | - | 0.06 |
603669 Earnings Reports FAQ
What is the earnings per share (EPS) for 603669?
EPS data for 603669 is currently not available, as Lionco Pharmaceutical Group Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately -35.52%, reflecting the 603669's performance and SSE market conditions.
When is the next earnings release date?
Lionco Pharmaceutical Group Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lionco Pharmaceutical Group Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 603669 at this time, as Lionco Pharmaceutical Group Inc has no recent EPS data to calculate it.
